Profilo
Kean Meng Toh is currently Executive Director, Chief Scientific Officer & VP at CK Life Sciences International (Holdings), Inc. since 2018 and Director at Dogwood Therapeutics, Inc. since 2024.
Formerly, Dr. Toh was Director at Virios Therapeutics, Inc. Education includes undergraduate and doctorate degrees from the National University of Singapore and a graduate degree from the University of London.
Posizioni attive di Kean Meng Toh
| Società | Posizione | Inizio |
|---|---|---|
| CK LIFE SCIENCES INT'L., (HOLDINGS) INC. | Direttore Tecnico/Scientifico/R&S | 15/11/2018 |
Precedenti posizioni note di Kean Meng Toh
| Società | Posizione | Fine |
|---|---|---|
Virios Therapeutics, Inc.
Virios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for fibromyalgia and other related conditions | Direttore/Membro del Consiglio | - |
Formazione di Kean Meng Toh
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Virios Therapeutics, Inc.
Virios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for fibromyalgia and other related conditions | Health Technology |
CK Life Sciences International (Holdings), Inc.
CK Life Sciences International (Holdings), Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceuticals, agriculture and nutraceuticals products | Health Technology |
National University of Singapore
National University of Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















